The university was founded in 1961 by a group of professors and students from the
medical school of the four-century-old National University of San Marcos in Lima. This group of students and professors expressed their strong disagreement with the current legislation, inspired by the
APRA party interested in the absolute control of the university system in the country. The legislation advocated the "co-government" of all the state universities by the so-called "student one-third", which would politicize the academic enterprise. The dissenting group was led by Drs.
Honorio Delgado and
Alberto Hurtado, dean of the medical school at
San Marcos. As their campaign to preserve academics failed, the 400 plus faculty members had no other option but to resign en masse, and found the new medical school as a private non-profit academic institution. On September 22, the decree authorizing the new university school with the name of
Private Peruvian University of Medical and Biological Sciences was issued. The official inauguration of the new university took place on June 18, 1962, with the assistance of the President of the Republic,
Manuel Prado Ugarteche. It would be on February 24, 1965, when the institution changes its name to the one it currently has:
Cayetano Heredia University. The first classes began in April 1962, in the old headquarters of the Colegio Sagrados Corazones Belén del
Jirón de la Unión, and after the opening of the Cayetano Heredia National Hospital in 1967, they moved to the new headquarters of
San Martín de Porres in 1968. Some have suggested that these events were the subject of "prior arrangements/agreements" which, in the political context of the time, would have been practically impossible. 47 years later, Cayetano Heredia and San Marcos are the most prestigious medical schools in Peru.
Vaccine-Gate case The
Vaccine-gate case (Vacuna
gate in Spanish) is a case of corruption that occurred in the second half of 2020 and early 2021 with respect to an extra 1,000 batch of experimental
vaccines from the pharmaceutical company
Sinopharm granted to the Cayetano Heredia University destined for the Phase 3 clinical trials personnel. The controversy arose when it was discovered that some of this doses were given to senior officials of the Peruvian State (including the
President of the Republic of Peru at that time:
Martín Vizcarra and his minister of health
Pilar Mazzetti), workers of the research project on the use of the vaccine in the Peruvian population and high University authorities, including the rector of the university Luis Varela Pinedo, his vice-rector José Ronald Espinoza Babilón and the researcher and ex-minister
Patricia J. García, who among other authorities of the educational center, had to resign on February 18 as a result of the scandal. On February 16, the situation was aggravated when it was discovered that Germán Málaga Rodríguez, project leader at the Cayetano Heredia headquarters, administered three doses to 40 people, including himself and a deputy minister, irregularly and without written consent. On February 19, after an inspection in which various irregularities that violated the study protocol, good practices and ethical standards were corroborated, the
National Institute of Health of Peru determined the departure of the principal investigator responsible, Germán Málaga, and suspended to the university as a center for conducting new clinical trials. ==Organization==